Resistance to High-Fat Diet-Induced Obesity and Insulin Resistance in Mice with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Mitochondrial fatty acid oxidation provides an important energy source for cellular metabolism and decreased mitochondrial fatty acid oxidation has been implicated in the pathogenesis of type 2 diabetes. Paradoxically, mice with an inherited deficiency of the mitochondrial fatty acid oxidation enzyme, very long chain acyl-CoA dehydrogenase (VLCAD), manifested increased fatty acid oxidation in liver, muscle and brown adipose tissue and a lower whole body respiratory quotient compared to WT mice. Moreover, VLCAD−/− mice were protected from fat-induced liver and muscle insulin resistance, which was associated with reduced intracellular diacylglycerol content and decreased activity of protein kinase Cε and protein kinase Cθ in liver and muscle respectively. The increased insulin sensitivity in the VLCAD−/− mice was associated with increased liver and muscle AMPK activity and increased PPARα expression in muscle and brown adipose tissue. Taken together these data suggest that VLCAD−/− mice were protected from diet-induced obesity and insulin resistance due to chronic activation of AMPK (liver and muscle) and PPARα (muscle and BAT) activity resulting in increased fatty acid oxidation and decreased intramyocellular and hepatocellular diacylglycerol content. Furthermore these data demonstrate that mitochondrial dysfunction can paradoxically result in increased insulin sensitivity due to these compensatory mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Mitochondrial dysfunction with impaired skeletal muscle oxidative phosphorylation has been implicated in the pathogenesis of insulin resistance and type 2 diabetes mellitus (T2DM) (Kelley et al., 2002; Petersen et al., 2003; Mootha et al., 2003; Patti et al., 2003; Petersen et al., 2004).”
BackgroundSelf-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 2×
“Mitochondrial dysfunction with impaired skeletal muscle oxidative phosphorylation has been implicated in the pathogenesis of insulin resistance and type 2 diabetes mellitus (T2DM) (Kelley et al., 2002; Petersen et al., 2003; Mootha et al., 2003; Patti et al., 2003; Petersen et al., 2004).”
BackgroundSelf-citationPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 5×
“…via LCAD activity as an alternative step to the deficient VLCAD step, resulting in a net reduction of DAG, which has been implicated in the patho- 406 Cell Metabolism 11, 402–411, May 5, 2010 ª2010 Elsevier Inc. genesis of muscle and liver insulin resistance (Yu et al., 2002; Samuel et al., 2004).”
BackgroundMethodInfluentialSelf-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 8×
“…via LCAD activity as an alternative step to the deficient VLCAD step, resulting in a net reduction of DAG, which has been implicated in the patho- 406 Cell Metabolism 11, 402–411, May 5, 2010 ª2010 Elsevier Inc. genesis of muscle and liver insulin resistance (Yu et al., 2002; Samuel et al., 2004).”
BackgroundMethodSelf-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · cited 1×
“Increases in tissue ceramide content have been implicated in fat-induced insulin resistance (Holland et al., 2007); however, in contrast to the increase in liver and muscle DAG concentrations of insulin-resistant WT mice, there were no differences in liver or skeletal muscle ceramide concentrations…”
BackgroundStorlien, L. H., Jenkins, A. B., Chisholm, D. J., Pascoe, W. S., Khouri, S., & Kraegen, E. W. (1991) · Diabetes · doi:10.2337/diab.40.2.280 · Cited by 967
Mootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M., Wisniewski, J. R., Stahl, E., Bolouri, M. S., Ray, H. N., Sihag, S., Kamal, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00926-7 · Cited by 889
Alessi, D. R., Barry Caudwell, F., Andjelkovic, M., Hemmings, B. A., & Cohen, P. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01370-1 · Cited by 628
Obici, S., Feng, Z., Arduini, A., Conti, R., & Rossetti, L. (2003) · Nature Medicine · doi:10.1038/nm873 · Cited by 548 · cited 4×
“To investigate whether protection from dietinduced obesity in the VLCAD / mice was due to downstream effects of VLCAD deficiency and hypothalamic control of feeding behavior due to increased long-chain acyl-CoAs, as suggested by Obici and colleagues (Obici et al., 2003), we measured acyl-CoAs in the hypothalamus and f…”
BackgroundInfluentialSamuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 1×
“…in liver and skeletal muscle commensurate with reduced PKC3 and PKCq activity, respectively, which have been shown to cause insulin resistance in these tissues (Griffin et al., 1999; Yu et al., 2002; Samuel et al., 2004; Neschen et al., 2005; Savage et al., 2006; Samuel et al., 2007) (Figure 5).”
BackgroundSelf-citationSavage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447 · cited 2×
“…in liver and skeletal muscle commensurate with reduced PKC3 and PKCq activity, respectively, which have been shown to cause insulin resistance in these tissues (Griffin et al., 1999; Yu et al., 2002; Samuel et al., 2004; Neschen et al., 2005; Savage et al., 2006; Samuel et al., 2007) (Figure 5).”
BackgroundMechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8456 · Cited by 443 · cited 3×
“For the determination of tissue 2-[(14)C]-deoxyglucose-6-phosphate content, tissue samples were homogenized, and the supernatants were subjected to an ion-exchange column to separate 2-deoxyglucose-6-phosphate from 2-deoxyglucose, as described previously (Kim et al., 2000).”
MethodInfluentialSelf-citationPospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.047 · Cited by 404 · cited 2×
“…in specific steps, such as VLCAD, mitochondrial fatty acid oxidation as observed in the VLCAD / mice, and other mouse models (Wredenberg et al., 2006; Pospi- silik et al., 2007), can promote increased insulin-stimulated glucose metabolism by compensatory mechanisms involving activation of AMPK and…”
BackgroundFan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343 · cited 5×
“Previous studies have shown compensatory up regulation of PPARα activity on its target genes in response to a deficiency of the peroxisomal fatty acid oxidation enzyme acyl-CoA oxidase (AOX) (Fan et al., 1998).”
BackgroundInfluentialZhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707060104 · Cited by 291 · cited 6×
“In contrast, however, the deficiency of fatty acid oxidation in the LCAD / mice did not lead to activation of AMPK (Figure 4B) in liver or muscle; thus, there was no compensation in fatty acid oxidation, resulting in exacerbated hepatic insulin resistance in these mice (Zhang et al., 2007).”
BackgroundInfluentialSelf-citationNeschen, S., Morino, K., Hammond, L. E., Zhang, D., Liu, Z.-X., Romanelli, A. J., Cline, G. W., Pongratz, R. L., Zhang, X.-M., Choi, C. S., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.006 · Cited by 261 · cited 2×
“…in liver and skeletal muscle commensurate with reduced PKC3 and PKCq activity, respectively, which have been shown to cause insulin resistance in these tissues (Griffin et al., 1999; Yu et al., 2002; Samuel et al., 2004; Neschen et al., 2005; Savage et al., 2006; Samuel et al., 2007) (Figure 5).”
BackgroundSelf-citationRespiratory chain dysfunction in skeletal muscle does not cause insulin resistance
Wredenberg, A., Freyer, C., Sandström, M. E., Katz, A., Wibom, R., Westerblad, H., & Larsson, N.-G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.029 · Cited by 141 · cited 2×
“…and that reductions in specific steps, such as VLCAD, mitochondrial fatty acid oxidation as observed in the VLCAD / mice, and other mouse models (Wredenberg et al., 2006; Pospi- silik et al., 2007), can promote increased insulin-stimulated glucose metabolism by compensatory mechanisms…”
Background
Cited by
A Mouse Model of Diet-Induced Obesity and Insulin Resistance
Wang, C.-Y., & Liao, J. K. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-430-8_27 · Cited by 516
Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance
Amati, F., Dubé, J. J., Alvarez-Carnero, E., Edreira, M. M., Chomentowski, P., Coen, P. M., Switzer, G. E., Bickel, P. E., Stefanovic-Racic, M., Toledo, F. G. S., et al. (2011) · Diabetes · doi:10.2337/db10-1221 · Cited by 395
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Self-citationLipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343
Lee, H.-Y., Choi, C. S., Birkenfeld, A. L., Alves, T. C., Jornayvaz, F. R., Jurczak, M. J., Zhang, D., Woo, D. K., Shadel, G. S., Ladiges, W., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.004 · Cited by 319
“Rates of basal and insulin-stimulated whole-body glucose fluxes and tissue glucose uptake were determined by bolus (10 mCi) injection of 2-deoxy-D-[1-(14)C]glucose (2-DOG) (PerkinElmer) as described (Samuel et al., 2006; Zhang et al., 2010).”
InfluentialSelf-citation
Metadata
- Authors
- Zhang, D., Christianson, J., Liu, Z.-X., Tian, L., Choi, C. S., Neschen, S., Dong, J., Wood, P. A., & Shulman, G. I.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 11
- Issue
- 5
- Pages
- 402-411
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2131915860
- Cited by
- 84
- References
- 20
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.